Schwartz CDC nomination advances
Analysis based on 6 articles · First reported Jul 30, 2026 · Last updated Jul 30, 2026
The nomination's advancement provides some stability for the CDC, but ongoing political interference and workforce depletion continue to undermine public health credibility. Vaccine-related companies may face uncertainty if anti-vaccine policies gain traction.
The United States — United States Senate Committee on Health, Education, Labor and Pensions voted to advance Dr. Erica Schwartz's nomination to be CDC director, despite concerns about her willingness to resist political interference from Health Secretary Robert F. Kennedy Jr. Schwartz, a former deputy surgeon general, would be the 22nd CDC director if confirmed by the full Senate. The CDC has been in turmoil under President Donald Trump, losing over 3,000 employees and facing leadership instability. Kennedy has attempted to rewrite vaccine recommendations, which were put on hold by a federal judge. Public health groups remain skeptical of Schwartz's independence.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard